Radiotherapy

• 

  Subject Areas on Research

  • 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). 
  • 73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer. 
  • A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. CNS Cancer Consortium. 
  • A genetic algorithm for variable selection in logistic regression analysis of radiotherapy treatment outcomes. 
  • A hardware investigation of robotic SPECT for functional and molecular imaging onboard radiation therapy systems. 
  • A hybrid strategy of offline adaptive planning and online image guidance for prostate cancer radiotherapy. 
  • A method to study the characteristics of 3D dose distributions created by superposition of many intensity-modulated beams delivered via a slit aperture with multiple absorbing vanes. 
  • A neural network to predict symptomatic lung injury. 
  • A novel digital tomosynthesis (DTS) reconstruction method using a deformation field map. 
  • A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract. 
  • A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019. 
  • A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. 
  • A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients. 
  • A practical three-dimensional dosimetry system for radiation therapy. 
  • Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma. 
  • Accelerating reconstruction of reference digital tomosynthesis using graphics hardware. 
  • Acquired vulvar lymphangioma circumscriptum: a comparison of 12 cases with Crohn's associated lesions or radiation therapy induced tumors. 
  • Activities and accomplishments of the cancer and leukemia group B genitourinary committee. 
  • Adenocarcinoma of the prostate: an expensive way to die. 
  • Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer. 
  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. 
  • Adult respiratory distress syndrome after limited thoracic radiotherapy. 
  • Advances in radiotherapy for tumors involving the mediastinum. 
  • Algorithms and functionality of an intensity modulated radiotherapy optimization system. 
  • An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects. 
  • An image-guided technique for planning and verification of supine craniospinal irradiation. 
  • Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases. 
  • Analysis of results of radiation therapy for Stage II carcinoma of the cervix. 
  • Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy. 
  • Angiosarcoma of the eyelid: a clinicopathologic comparison between isolated unilateral tumors and tumors demonstrating extrapalpebral involvement. 
  • Antiemetics: American Society of Clinical Oncology clinical practice guideline update. 
  • Application of dose compensation in image-guided radiotherapy of prostate cancer. 
  • Arc-modulated radiation therapy based on linear models. 
  • Assessing the risk of breast cancer. 
  • Assessment of baroreflex control from beat-to-beat blood pressure and heart rate changes: a validation study. 
  • Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. 
  • Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter? 
  • Biological and clinical aspects of hyperthermia in cancer therapy. 
  • Blocking [211At]astatide accumulation in normal tissues: preliminary evaluation of seven potential compounds. 
  • Breast Cancer Version 2.2015. 
  • Breast cancer after chest radiation therapy for childhood cancer. 
  • Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. 
  • Breast conservation: is the survival better for mastectomy? 
  • Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? 
  • Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy. 
  • Carcinoma of the Middle Ear: A Review of the National Cancer Database. 
  • Carcinoma of the cervix, stage III. Results of radiation therapy. 
  • Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. 
  • Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. 
  • Cardiac tamponade complicating trimodal therapy for malignant mesothelioma. 
  • Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement. 
  • Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study. 
  • Caring for survivors of childhood cancer: it takes a village. 
  • Case records of the Massachusetts General Hospital. Case 20-2005. A 58-year-old man with locally advanced pancreatic cancer. 
  • Cataract surgery and intraocular lens implantation in patients with retinoblastoma. 
  • Characterization of a 137Cs irradiator from a new perspective with modern dosimetric tools. 
  • Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. 
  • Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. 
  • Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. 
  • Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. 
  • Chronic ear surgery in irradiated temporal bones. 
  • Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis. 
  • Colon cancer. 
  • Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. 
  • Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809. 
  • Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. 
  • Commissioning a small-field biological irradiator using point, 2D, and 3D dosimetry techniques. 
  • Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. 
  • Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics. 
  • Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. 
  • Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma. 
  • Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials. 
  • Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. 
  • Complications of therapy for testicular cancer. 
  • Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma. 
  • Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. 
  • Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. 
  • Cone-beam-CT guided radiation therapy: A model for on-line application. 
  • Cone-beam-CT guided radiation therapy: technical implementation. 
  • Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. 
  • Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. 
  • Critical review of radical cystectomy and indicators of prognosis. 
  • Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. 
  • Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. 
  • Current and emerging treatment strategies for anal cancer. 
  • Cushing's disease. A review. 
  • Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapy. 
  • Cytoprotection for radiation-associated normal tissue injury. 
  • Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness. 
  • Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? 
  • Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab. 
  • Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy. 
  • Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024. 
  • Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. 
  • Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia. 
  • Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy. 
  • Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma. 
  • Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha. 
  • Enhancing Radiation Therapy Through Cherenkov Light-Activated Phototherapy. 
  • Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. 
  • Esophageal and esophagogastric junction cancers. 
  • Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trials. 
  • Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014. 
  • Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. 
  • Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. 
  • Exercise as Adjunct Therapy in Cancer. 
  • Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. 
  • Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer. 
  • Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing. 
  • Fiber-optic detector for real time dosimetry of a micro-planar x-ray beam. 
  • Fine structure of a radiation-induced osteogenic sarcoma. 
  • First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma. 
  • Fractionated external-beam radiation therapy for meningiomas of the cavernous sinus. 
  • Functional assay to guide precision radiotherapy by assessing individual patient radiosensitivity. 
  • Future directions in toxicity prevention. 
  • Future directions in toxicity prevention. 
  • Gastric ulceration in a patient treated with SIR-spheres. 
  • Gemcitabine-induced radiation recall myositis. 
  • Generating arbitrary one-dimensional dose profiles using rotational therapy. 
  • Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy. 
  • Genomic prediction of locoregional recurrence after mastectomy in breast cancer. 
  • Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy. 
  • Glioblastoma multiforme: a review of where we have been and where we are going. 
  • Goal-Driven Beam Setting Optimization for Whole-Breast Radiation Therapy. 
  • Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations. 
  • Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. 
  • HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. 
  • Hair regrowth after cancer therapy. 
  • Hedgehog Signaling is Associated with Liver Response to Fractionated Irradiation in Mice. 
  • Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone. 
  • Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. 
  • High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. 
  • Hodgkin lymphoma. 
  • How should we measure and report radiotherapy-induced xerostomia? 
  • Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. 
  • Hyperlucent lung after radiation therapy. 
  • Iatrogenic lesions of soft tissue and bone. 
  • Imaging findings of hemorrhagic cystitis in pediatric oncology patients. 
  • Imaging of late complications from mantle field radiation in lymphoma patients. 
  • Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study. 
  • Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. 
  • Implementing a mHealth intervention to increase colorectal cancer screening among high-risk cancer survivors treated with radiotherapy in the Childhood Cancer Survivor Study (CCSS). 
  • Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery. 
  • Improving calibration accuracy in gel dosimetry. 
  • Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy. 
  • In memoriam: Edward L Gillette (1932-2006). 
  • In regard to Ghaly et al., IJROBP 2003;55:1288-1293. 
  • In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153). 
  • Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. 
  • Inconsistent mammography perceptions and practices among women at risk of breast cancer following a pediatric malignancy: a report from the Childhood Cancer Survivor Study. 
  • Incorporating palliative radiotherapy education into hospice and palliative medicine fellowship training: a feasibility study. 
  • Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group. 
  • Indications for adjuvant radiotherapy in extrapelvic colonic carcinoma. 
  • Individual prediction of heart failure among childhood cancer survivors. 
  • Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A patterns of care study. 
  • Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. 
  • Input/output characteristics of a matrix ion-chamber electronic portal imaging device. 
  • Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study. 
  • Intelligence and adaptive function in children diagnosed with brain tumour during infancy. 
  • Interrater Reliability in Toxicity Identification: Limitations of Current Standards. 
  • Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235. 
  • Intersociety Council on Radiation Oncology essay on the introduction of new medical treatments into practice. 
  • Intracranial atherosclerosis following radiotherapy. 
  • Intraoperatic electron beam irradiation in pancreatic cancer. 
  • Intraoperative irradiation: current and future status. 
  • Introduction: The science of survivorship: moving from risk to risk reduction. 
  • Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas. 
  • Irradiation and immunotherapy: From concept to the clinic. 
  • Is there a role for advanced radiation therapy technologies in the treatment of pancreatic adenocarcinoma? 
  • Is there a role for selective neck dissection after chemoradiation for head and neck cancer? 
  • Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer? 
  • Late complications after marrow transplantation. 
  • Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid. 
  • Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. 
  • Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019. 
  • Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. 
  • Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators. 
  • Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. 
  • Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. 
  • Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study. 
  • Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. 
  • Long-term risk of medical conditions associated with breast cancer treatment. 
  • Long-term use of temozolomide: could you use temozolomide safely for life in gliomas? 
  • Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. 
  • Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study. 
  • Low-Grade Papillary Schneiderian Carcinoma of the Sinonasal Cavity and Temporal Bone. 
  • Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort. 
  • Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases. 
  • Management of cancer in the aged. 
  • Management of glioma in Victoria (1998-2000): retrospective cohort study. 
  • Management of hearing in pediatric NF2. 
  • Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series. 
  • Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. 
  • Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). 
  • Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series. 
  • Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. 
  • Multiple authorship in two English-language journals in radiation oncology. 
  • Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture. 
  • NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017. 
  • NCCN Task Force Report. prevention and management of mucositis in cancer care. 
  • NCCN clinical practice guidelines in oncology: prostate cancer. 
  • Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer. 
  • Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma. 
  • Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy. 
  • Neutron-photon treatment: modern day Pyrrhic victory? Regarding Haraf et al. IJROBP 33(1): 3-14; 1995. 
  • No association between TGFB1 polymorphisms and late radiotherapy toxicity: a meta-analysis. 
  • Non-human to human organ transplantation: its biologic basis and a potential role for radiation therapy. 
  • Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. 
  • Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. 
  • Outcome research: prostate cancer databases. 
  • Pancreatoblastoma in a teenage patient. 
  • Particle therapy and treatment of cancer. 
  • Pathogenesis of radiation-induced capsular contracture in tissue expander and implant breast reconstruction. 
  • Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. 
  • Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer. 
  • Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. 
  • Physical penumbra change of beam profile due to film digitization. 
  • Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. 
  • Polymer gel dosimetry. 
  • Postradiation cerebellar necrosis mimicking tumor: MR appearance. 
  • Predicting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm. 
  • Predicting a local recurrence after breast-conserving therapy by gene expression profiling. 
  • Predicting radiotherapy-induced cardiac perfusion defects. 
  • Predicting toxicity from radiation therapy--it's genetic, right? 
  • Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. 
  • Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. 
  • Primary intradural extraosseous Ewing sarcoma of the spine: case report and literature review. 
  • Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. 
  • Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers. 
  • Prospective trial of a video educational tool for radiation oncology patients. 
  • Prostate cancer: diagnosis, treatment, and experience at one tertiary-care military medical center, 1989 and 1994. 
  • Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival. 
  • Prostate-specific antigen as a marker of disease activity in prostate cancer. 
  • Prostate-specific antigen as a marker of disease activity in prostate cancer. 
  • Pulmonary function abnormalities in long-term survivors of childhood cancer. 
  • Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations. 
  • Radiation Dermatitis: A Prevention Protocol for Patients With Breast Cancer. 
  • Radiation Records in the National Cancer Database: Variations in Coding and/or Practice Can Significantly Alter Survival Results. 
  • Radiation dose-volume effects in the spinal cord. 
  • Radiation dose-volume effects of optic nerves and chiasm. 
  • Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer. 
  • Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 Patterns of Care process survey. 
  • Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma^. 
  • Radiation therapy in anal and rectal cancer. 
  • Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study. 
  • Radiation-associated valvular heart disease. 
  • Radiation-blocking shields to localize periarticular radiation precisely for prevention of heterotopic bone formation around uncemented total hip arthroplasties. 
  • Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. 
  • Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model. 
  • Radiation-induced lung injury. Assessment, management, and prevention. 
  • Radiation-induced malignant gliomas: a current review. 
  • Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints. 
  • Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. 
  • Radiofrequency ablation of liver tumors: influence of technique and tumor size. 
  • Radiolabeling and in vitro evaluation of (67)Ga-NOTA-modular nanotransporter--a potential Auger electron emitting EGFR-targeted radiotherapeutic. 
  • Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time. 
  • Radiotherapy and radiosurgery for tumors of the central nervous system. 
  • Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. 
  • Radiotherapy versus surgery for localized prostatic cancer. 
  • Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer. 
  • Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report. 
  • Re: Researchers make slow headway in managing dry mouth. 
  • Re: The development of erectile dysfunction in men treated for prostate cancer. 
  • Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. 
  • Rectourethral fistulas in the cancer survivor. 
  • Relationship between the generalized equivalent uniform dose formulation and the Poisson statistics-based tumor control probability model. 
  • Renal complications secondary to radiation treatment of upper abdominal malignancies. 
  • Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. 
  • Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma. 
  • Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide. 
  • Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor. 
  • Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. 
  • Role of oxidative stress in a rat model of radiation-induced erectile dysfunction. 
  • Routine screening for depression in radiation oncology patients. 
  • Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer. 
  • SET8 Inhibition Potentiates Radiotherapy by Suppressing DNA Damage Repair in Carcinomas. 
  • Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer. 
  • Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial. 
  • Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. 
  • Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms with distinct genotypic profiles suggestive of biclonality in a single individual. 
  • Severe subcutaneous hemiatrophy following treatment of Wilms' tumor: CT demonstration. 
  • Signet-ring cells in the bone marrow as an indication of cryptic metastasis of breast carcinoma: A case report. 
  • Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. 
  • Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. 
  • Sinonasal carcinoma after irradiation for medulloblastoma in nevoid basal cell carcinoma syndrome. 
  • Skin metastases confined to a field of previous irradiation. Report of two cases and review of the literature. 
  • Small cell lung cancer. 
  • Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. 
  • Soft-tissue sarcomas: MR imaging and MR spectroscopy for prognosis and therapy monitoring. Work in progress. 
  • Solid tumor second primary neoplasms: who is at risk, what can we do? 
  • Somnolence syndrome after focal radiation therapy to the pineal region: case report and review of the literature. 
  • Special concerns for survivors of prostate cancer. 
  • Special report: workshop on 4D-treatment planning in actively scanned particle therapy--recommendations, technical challenges, and future research directions. 
  • Sphincter preservation in rectal cancer. 
  • Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors. 
  • Surgical management of high-risk, localized prostate cancer. 
  • Survival outcomes in sinonasal carcinoma with neuroendocrine differentiation: A NCDB analysis. 
  • Survivorship after childhood, adolescent, and young adult cancer. 
  • Symptom distress, catastrophic thinking, and hope in nasopharyngeal carcinoma patients. 
  • Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion. 
  • Synopsis of history of American Society for Therapeutic Radiology and Oncology 1958-2008. 
  • System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-Directed Clinical Evaluations During Radiation and Chemoradiation. 
  • Systemic Therapies for Melanoma Brain Metastases: A Primer for Radiologists. 
  • TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases. 
  • Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland. 
  • Targeted therapy using alpha emitters. 
  • Task Group 142 report: quality assurance of medical accelerators. 
  • Task Group 174 Report: Utilization of [18 F]Fluorodeoxyglucose Positron Emission Tomography ([18 F]FDG-PET) in Radiation Therapy. 
  • Technical Note: On maximizing Cherenkov emissions from medical linear accelerators. 
  • Techniques of experimental animal radiotherapy. 
  • Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. 
  • The DNA damage response: implications for tumor responses to radiation and chemotherapy. 
  • The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress. 
  • The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. 
  • The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma. 
  • The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation. 
  • The audition elective. 
  • The characteristics of bladder cancer after radiotherapy for prostate cancer. 
  • The chemoradiation paradigm in head and neck cancer. 
  • The effect of detector size to the broadening of the penumbra--a computer simulated study. 
  • The effect of radiation therapy on the fixation strength of an experimental porous-coated implant in dogs. 
  • The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. 
  • The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians. 
  • The impact of advanced technologies on treatment deviations in radiation treatment delivery. 
  • The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer. 
  • The localisation of radiolabelled murine monoclonal antibody 81C6 and its Fab fragment in human glioma xenografts in athymic mice. 
  • The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care Study. 
  • The prevention and treatment of radiotherapy - induced xerostomia. 
  • The risk of carotid stenosis in head and neck cancer patients after radiation therapy. 
  • The role of amifostine as a radioprotector. 
  • The role of functional imaging in the diagnosis and management of late normal tissue injury. 
  • The role of surgery and ablative radiotherapy in oligometastatic breast cancer. 
  • Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review. 
  • Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. 
  • Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older. 
  • Tracheomegaly. 
  • Tradeoffs of integrating real-time tracking into IGRT for prostate cancer treatment. 
  • Treatment field shape verification using elliptic Fourier transform. 
  • Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. 
  • Treatment of head and neck cancer. 
  • Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. 
  • Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. 
  • Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals. 
  • Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. 
  • Unintended exposure in radiotherapy: identification of prominent causes. 
  • Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010. 
  • Updates on Merkel Cell Carcinoma. 
  • Urethroplasty for radiotherapy induced bulbomembranous strictures: a multi-institutional experience. 
  • Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer. 
  • Using Artificial Intelligence to Improve the Quality and Safety of Radiation Therapy. 
  • Using lithium as a neuroprotective agent in patients with cancer. 
  • Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed. 
  • Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. 
  • Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). 
  • Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions. 
  • Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. 
  • Vision-Targeted Health-Related Quality of Life in Adult Survivors of Retinoblastoma. 
  • Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision. 
  • WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. 
  • We need better randomized comparison trials of prostate cancer. 
  • What Should We Tell Patients About Physical Activity After a Prostate Cancer Diagnosis? 
  • Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. 
  • X-rays at the bar, 1896-1910. 
  • [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part II: radiobiological and immunologic strategies]. 
  • [Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases]. 
  • p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Charles, Hal Cecil, Adjunct Associate Professor in the Department of Radiology, Radiology
  • Cohen, Seth Morris, Professor of Head and Neck Surgery & Communication Sciences, Head and Neck Surgery & Communication Sciences
  • Craciunescu, Oana, Professor of Radiation Oncology, Radiation Oncology
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • Moorman, Patricia Gripka, Professor Emeritus in Family Medicine and Community Health, Duke Cancer Institute
  • O'Daniel, Jennifer Colleen, Assistant Professor of Radiation Oncology, Radiation Oncology
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Reitman, Zachary James, Assistant Professor of Radiation Oncology, Pathology
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Woodward, Julie Ann, Professor of Ophthalmology, Dermatology
  • Yoo, Sua, Associate Professor of Radiation Oncology, Radiation Oncology